Dysport
Dysport is a biological therapy with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
57.1%
4 of 7 finished
42.9%
3 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines
Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea
Botulinum Toxin Injection for Functional Popliteal Artery Entrapment Syndrome
Assessment of Gait After Dysport Treatment
Clinical Trials (10)
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines
Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea
Botulinum Toxin Injection for Functional Popliteal Artery Entrapment Syndrome
Assessment of Gait After Dysport Treatment
Phase IV Study On Muscle Activity Of Two Commercial Preparations Of Botulinum
Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial
The Impact of Botulinum Toxin on Brow Height and Morphology: A Randomized Controlled Trial
Upper Facial Remodeling With Perlane-L and Dysport
Brow Lifting With Dysport
All 10 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 10